X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (24) 24
index medicus (22) 22
middle aged (20) 20
female (19) 19
male (19) 19
oncology (17) 17
aged (16) 16
lung neoplasms - genetics (16) 16
non-small cell lung cancer (16) 16
chemotherapy (14) 14
carcinoma, non-small-cell lung - genetics (12) 12
lung cancer (11) 11
lung neoplasms - drug therapy (11) 11
lung neoplasms - pathology (11) 11
prognosis (11) 11
lung cancer, non-small cell (10) 10
carcinoma, non-small-cell lung - drug therapy (9) 9
cell lung-cancer (9) 9
genetic aspects (9) 9
mutation (9) 9
cancer (8) 8
erlotinib (8) 8
adenocarcinoma - genetics (7) 7
adult (7) 7
carcinoma, non-small-cell lung - pathology (7) 7
docetaxel (7) 7
genes (7) 7
receptor, epidermal growth factor - genetics (7) 7
survival (7) 7
adenocarcinoma (6) 6
cancer research (6) 6
gefitinib (6) 6
metastasis (6) 6
adenocarcinoma - pathology (5) 5
analysis (5) 5
association (5) 5
care and treatment (5) 5
chemistry (5) 5
crizotinib (5) 5
mutation - genetics (5) 5
neoplasm staging (5) 5
nsclc (5) 5
predictive value of tests (5) 5
adenocarcinoma of lung (4) 4
beer (4) 4
biochemistry (4) 4
biomedicine (4) 4
compositions or test papers therefor (4) 4
compositions thereof (4) 4
condition-responsive control in microbiological orenzymological processes (4) 4
culture media (4) 4
derivatives thereof (4) 4
dna-binding proteins - genetics (4) 4
egfr (4) 4
egfr gene mutations (4) 4
egfr mutation (4) 4
enzymology (4) 4
follow-up studies (4) 4
gene mutations (4) 4
genetic research (4) 4
growth-factor receptor (4) 4
immunotherapy (4) 4
lung cancer, small cell (4) 4
lung neoplasms - diagnosis (4) 4
measuring or testing processes involving enzymes, nucleicacids or microorganisms (4) 4
metallurgy (4) 4
microbiology (4) 4
microorganisms or enzymes (4) 4
mutation or genetic engineering (4) 4
non-small-cell lung cancer (4) 4
nucleic acids (4) 4
nucleosides (4) 4
nucleotides (4) 4
open-label (4) 4
organic chemistry (4) 4
pathology (4) 4
patients (4) 4
processes of preparing such compositions (4) 4
propagating, preserving or maintaining microorganisms (4) 4
research (4) 4
respiratory system (4) 4
retrospective studies (4) 4
single nucleotide polymorphisms (4) 4
single-nucleotide polymorphism (4) 4
smoking (4) 4
smoking - genetics (4) 4
spirits (4) 4
sugars (4) 4
trial (4) 4
tyrosine kinase inhibitors (4) 4
vinegar (4) 4
wine (4) 4
aged, 80 and over (3) 3
alk gene rearrangement (3) 3
alk rearrangement (3) 3
antineoplastic agents - therapeutic use (3) 3
asthma (3) 3
biochemistry & molecular biology (3) 3
biomarkers, tumor - genetics (3) 3
biomedicine general (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Brain Pathology, ISSN 1015-6305, 01/2018, Volume 28, Issue 1, pp. 77 - 86
Anaplastic lymphoma kinase (ALK) gene rearrangement was reported in 3%–7% of primary non‐small‐cell lung cancer (NSCLC) and its presence is commonly associated... 
CNS metastases | FISH | NSCLC | IHC | ALK rearrangement | EML4-ALK FUSION GENE | PATHOLOGY | IDENTIFICATION | NEUROSCIENCES | EGFR | CLINICAL NEUROLOGY | ANAPLASTIC LYMPHOMA KINASE | REARRANGEMENT | BRAIN METASTASES | CRIZOTINIB | ASSOCIATION | IMMUNOHISTOCHEMISTRY | Immunohistochemistry | Humans | Middle Aged | Image Interpretation, Computer-Assisted | Lung Neoplasms - pathology | Male | Central Nervous System Neoplasms - secondary | Adult | Female | Tissue Fixation | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Lung Neoplasms - enzymology | Carcinoma, Non-Small-Cell Lung - genetics | Early Detection of Cancer | Central Nervous System Neoplasms - genetics | Kaplan-Meier Estimate | In Situ Hybridization, Fluorescence | Receptor Protein-Tyrosine Kinases - metabolism | Central Nervous System Neoplasms - pathology | Receptor Protein-Tyrosine Kinases - genetics | Gene Rearrangement | Central Nervous System Neoplasms - enzymology | Aged | Carcinoma, Non-Small-Cell Lung - enzymology | Pattern Recognition, Automated | Lymphomas | Metastasis | Lung cancer, Non-small cell | Analysis | Central nervous system | Adenocarcinoma | Tyrosine | Abnormalities | Lung cancer | ALK protein | Fluorescence | Staining | Non-small cell lung carcinoma | Nervous system | Lung carcinoma | Paraffin | Macrophages | Patients | Lymphoma | Metastases | Demographics | Gene rearrangement | Fluorescence in situ hybridization | Lesions | Protein-tyrosine kinase | Smoking | Cancer
Journal Article
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, ISSN 1422-0067, 04/2019, Volume 20, Issue 8, p. 1915
Immunotherapy using immune checkpoints inhibitors has become the standard treatment for first and second line therapy in patients with non-small cell lung... 
immune-check points inhibitors | IMMUNITY | NSCLC | BIOCHEMISTRY & MOLECULAR BIOLOGY | tumor immunophenotype | OPEN-LABEL | GUT MICROBIOTA | ATEZOLIZUMAB | microbiome | DOCETAXEL | CHEMISTRY, MULTIDISCIPLINARY | CHEMOTHERAPY | CHECKPOINT BLOCKADE | HETEROGENEITY | tumor mutation burden | PD-L1 | NIVOLUMAB | PD-1 | EXPRESSION
Journal Article
Clinical & Experimental Metastasis, ISSN 0262-0898, 12/2013, Volume 30, Issue 8, pp. 1063 - 1071
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 01/2017, Volume 12, Issue 1, p. S819
Journal Article
Expert Review of Anticancer Therapy, ISSN 1473-7140, 11/2018, Volume 18, Issue 11, pp. 1077 - 1083
Introduction: There are no effective central nervous system (CNS) metastases prevention methods in lung cancer patients. Prophylactic cranial irradiation has a... 
non-small cell lung cancer | radiotherapy | Central nervous system metastases | chemotherapy | immunotherapy | molecularly targeted therapy | PROPHYLACTIC CRANIAL IRRADIATION | PHASE-II | OPEN-LABEL | EGFR | NEOADJUVANT CHEMOTHERAPY | ONCOLOGY | HIGH-RISK | ALECTINIB | BRAIN METASTASES | CRIZOTINIB | TERM-FOLLOW-UP | Index Medicus
Journal Article
Frontiers in Pharmacology, ISSN 1663-9812, 06/2017, Volume 8, p. 371
Various species of the Carlina genus have been used in traditional medicine in many countries to treat numerous skin disorders, including cancer. The objective... 
Triterpenes | Melanoma | Cytotoxicity | ERK1/2 phosphorylation | Chlorogenic acid | Carlina sp | Apoptosis | WILD | ACTIVATION | PROTOCATECHUIC ACID | melanoma | apoptosis | DEATH | BRAF | chlorogenic acid | triterpenes | GROWTH | PLANTS | PHARMACOLOGY & PHARMACY | MELANOMA-CELLS | cytotoxicity
Journal Article
Pathology and Oncology Research, ISSN 1219-4956, 07/2017, Volume 23, Issue 3, pp. 607 - 614
Multidrug resistance (MDR) remains a substantial problem in chemotherapy. The purpose of the study was to investigate potential factors, including MDR genes... 
MDR1 | ABCC2 | NSCLC | TUBB3 | Docetaxel | ABCB1 | PLATINUM | PATHOLOGY | CHEMOTHERAPY | TRIAL | ONCOLOGY | SLCO1B3 | EXPRESSION | ASSOCIATION | III BETA-TUBULIN | Lung Neoplasms - genetics | Lung Neoplasms - drug therapy | Drug Resistance, Multiple - genetics | Prognosis | Carcinoma, Non-Small-Cell Lung - genetics | Humans | Middle Aged | Genotype | Tubulin - genetics | Disease Progression | Taxoids - therapeutic use | Drug Resistance, Neoplasm - genetics | Polymorphism, Single Nucleotide - genetics | Female | Multidrug Resistance-Associated Proteins - genetics | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | ATP Binding Cassette Transporter, Sub-Family B - genetics | Medical colleges | Drug resistance in microorganisms | Oncology, Experimental | Genes | Development and progression | Lung cancer, Small cell | College teachers | Research | Lung cancer, Non-small cell | Gene expression | Chemotherapy | Physiological aspects | Genetic research | Genetic aspects | Single nucleotide polymorphisms | Cancer | High resolution | Lung cancer | Medical services | Clinical trials | Single-nucleotide polymorphism | Proteins | MDR1 protein | MRP2 protein | Platinum | Risk assessment | Diagnosis | P-Glycoprotein | Medical research | Melting | Multidrug resistance | Health risks | Weight loss | Non-small cell lung carcinoma | Ribonucleic acid--RNA | Disease control | Patients | Survival | Prolongation | Smoking | Original
Journal Article
Journal of Cancer Research and Clinical Oncology, ISSN 0171-5216, 1/2015, Volume 141, Issue 1, pp. 61 - 68
Testing for the epidermal growth factor receptor (EGFR) gene mutations requires considerable multidisciplinary experience of clinicians (for appropriate... 
Medicine & Public Health | Hematology | Non-small cell lung cancer | Oncology | Cancer Research | Internal Medicine | TTF1 | EGFR gene | Mutation testing | Tyrosine kinase inhibitors | METAANALYSIS | ADENOCARCINOMA | METASTASES | SURGICAL PATHOLOGY SPECIMENS | TRIAL | ONCOLOGY | FACTOR RECEPTOR MUTATIONS | KRAS | INHIBITORS | ASSOCIATION | Receptor, Epidermal Growth Factor - genetics | Prognosis | Follow-Up Studies | Carcinoma, Squamous Cell - genetics | Humans | Middle Aged | Carcinoma, Squamous Cell - surgery | Lung Neoplasms - pathology | Male | Carcinoma, Large Cell - secondary | Carcinoma, Non-Small-Cell Lung - secondary | DNA Mutational Analysis | Polymerase Chain Reaction | Female | Adenocarcinoma - genetics | Carcinoma, Large Cell - genetics | Retrospective Studies | Lung Neoplasms - genetics | Carcinoma, Adenosquamous - surgery | Carcinoma, Non-Small-Cell Lung - surgery | Carcinoma, Non-Small-Cell Lung - genetics | Carcinoma, Adenosquamous - genetics | DNA-Binding Proteins - genetics | Mutation - genetics | Adenocarcinoma - secondary | Carcinoma, Large Cell - surgery | Carcinoma, Adenosquamous - secondary | Carcinoma, Squamous Cell - secondary | Lung Neoplasms - surgery | Aged | Transcription Factors | Neoplasm Staging | Adenocarcinoma - surgery | Care and treatment | Gene mutations | Oncology, Experimental | Genes | Lung cancer, Small cell | Genetic aspects | Research | Lung cancer, Non-small cell | Cancer | Original – Cancer Research
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 01/2017, Volume 12, Issue 1, pp. S939 - S940
Journal Article
Journal Article
Cancer Genetics, ISSN 2210-7762, 09/2019, Volume 237, pp. 10 - 18
Most drugs targeting PD-1 or PD-L1 are more effective when cancer cells of non-small cell lung cancer (NSCLC) patients express PD-L1 protein. The polymorphisms... 
Gene copy number | PD-L1 in NSCLC | Single nucleotide polymorphisms | Care and treatment | Genes | Antibodies | Lung cancer, Small cell | Lung cancer, Non-small cell | Viral antibodies | Anopheles | Messenger RNA | Analysis | Genetic research | Genetic aspects | Tumors
Journal Article
Oncotarget, ISSN 1949-2553, 2017, Volume 8, Issue 38, pp. 64283 - 64293
Different immunohistochemical (IHC) assays were approved for PD-L1 expression examination on tumor cells in qualification to immune-checkpoint inhibitors... 
ALK | PD-L1 | EGFR | Non-small cell lung cancer | non-small cell lung cancer | CELL LUNG-CANCER | NIVOLUMAB | DOCETAXEL | CELL BIOLOGY
Journal Article
Pathology & Oncology Research, ISSN 1219-4956, 1/2014, Volume 20, Issue 1, pp. 107 - 112
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.